Clinical Trials Logo
  1. Home
  2. Skin Cancer
  3. NCT03290989
  4. Details
NCT03290989 Clinical Trial

Itch and Pain Characteristics in Skin Carcinomas

Skin Cancer Clinical Trial

— PRURITCC  

Official title:
Itch and Pain Characteristics in Skin Carcinomas

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03290989
Other study ID # PRURITCC
Secondary ID
Status Completed
Phase N/A
First received September 14, 2017
Last updated September 18, 2017
Start date April 1, 2015
Est. completion date July 31, 2015

Study information
Verified date September 2017
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to have better knowledge about sensations of patients with skin carcinomas and to have data about characteristics of pain and pruritus . All patients presenting with a suspicions lesion for skin carcinomas will be included and will respond to a questionnaire. Demographics data, and histological data about skin carcinomas will be collected.

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date July 31, 2015
Est. primary completion date April 1, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

all patients with suspected skin carcinoma aged 18 years or more

Exclusion Criteria:

- age under 18 years,

- inability to complete the questionnaire because of cognitive impairment

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France CHRU de Brest Brest

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Evaluate characteristics of pruritus in skin carcinomas Questions about characteristics Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma)
Primary Evaluate characteristics of pruritus in skin carcinomas Numerical visual scale (EVA) Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
Primary Evaluate characteristics of pruritus in skin carcinomas 5D-itch scale Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
Primary Evaluate characteristics of pain in skin carcinomas Numerical visual pain Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
Primary Evaluate characteristics of in skin carcinomas score DN4 Day1 (when presenting at consultation with a skin lesion suspicious for carcinoma
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02721459 - XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma Phase 1
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05779423 - Cryoablation+Ipilimumab+Nivolumab in Melanoma Phase 2
Terminated NCT01468818 - Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma Phase 2
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Completed NCT00535769 - Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use Phase 0
Completed NCT00526032 - Melanoma Detection by Oblique-Incidence Optical Spectroscopy N/A
Completed NCT00588341 - Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection Phase 2
Active, not recruiting NCT01447199 - The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Enrolling by invitation NCT04758988 - AI Augmented Training for Skin Specialists N/A
Not yet recruiting NCT04534868 - Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area N/A
Recruiting NCT04138342 - Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer Phase 1
Completed NCT03673917 - Cosmetology Students and Skin Cancer N/A
Recruiting NCT04341064 - Sun-safe Habits Intervention and Education Phase 3
Completed NCT04206995 - Cancer Sensing: Evaluation of Odour Sampling Techniques
Recruiting NCT05574101 - A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer Phase 2
Not yet recruiting NCT05860881 - Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) Phase 3
Completed NCT05146622 - Virtual Sun Safe Workplaces Ph I
Recruiting NCT05068310 - Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors
Recruiting NCT03889899 - Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. N/A